Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 15 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Method for identifying bacteria in a sample
System and method for the analysis of biodiesel
Polymeric structures comprising a siloxane
Method for detecting motion of an electrical device or apparatus
High gradient lens for charged particle beam
Techniques for accessing a parallel database system via external programs using vertical and/or horizontal partitioning
Bessel beam plane illumination microscope
  Randomly Featured Patents
Mechanism for substantially preventing trail edge smear of an image on a receiver member
Reconfigurable optical add-drop multiplexers with servo control and dynamic spectral power management capabilities
Microstructuring optical wave guide devices with femtosecond optical pulses
Luminescent screen with grid structure for X-ray image intensifier
Security to extend trust
Wave-making apparatus
Process for manufacturing olefinic oligomers having lubricating properties
Cassette storage file
Numerically controlled curved surface machining unit
Waterproof thermal management module and portable